Despite the increased use of active surveillance as primary management for small renal tumours, there is a paucity of data regarding its effect on quality of life. A recent study suggests that uncertainty of illness could predict decreased quality of life in patients undergoing active surveillance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Parker, P. A. et al. Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. Eur Urol. http://dx.doi.org/10.1016/j.eururo.2013.01.034.
Crispen, P. L. et al. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer 112, 1051–1057 (2008).
Leveridge, M. J. et al. Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy. Eur. Urol. 60, 578–584 (2011).
Lane, B. R. et al. Renal mass biopsy—a renaissance? J. Urol. 179, 20–27 (2008).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Crispen, P. The effect of illness uncertainty during active surveillance. Nat Rev Urol 10, 255–256 (2013). https://doi.org/10.1038/nrurol.2013.63
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.63
